CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Real-World Clinical Outcomes and Prognostic Factors for Patients with Advanced Angiosarcoma who Received Systemic Treatment
Changhee Park, Miso Kim, Yoonjin Kwak, Kyung Chul Moon, Se Hyun Kim, Bhumsuk Keam, Yu Jung Kim, Tae Min Kim, Dong-Wan Kim
Cancer Research and Treatment. 2021;53(4):1195-1203.   Published online 2021 February 1    DOI: https://doi.org/10.4143/crt.2020.1337

Excel Download

Real-World Clinical Outcomes and Prognostic Factors for Patients with Advanced Angiosarcoma who Received Systemic Treatment
Cancer Research and Treatment. 2021;53(4):1195-1203   Crossref logo
Link1 Link2 Link3

P-245: Real-world outcomes in multiple myeloma (MM) patients who received subsequent therapy after daratumumab from the PREAMBLE study
Clinical Lymphoma Myeloma and Leukemia. 2022;22:S170   Crossref logo
Link1 Link2

Real-world clinical profile, treatment patterns and patient-reported outcomes in a subset of HR+/HER2- advanced breast cancer patients with poor prognostic factors: data from an international study
ESMO Open. 2021;6(4):100226   Crossref logo
Link1 Link2

Expediting Discharge in Hospitalized, Adult Patients with Skin and Soft Tissue Infections Who Received Empiric Vancomycin Therapy with Oritavancin: Description of Findings from an Institutional Pathway
Drugs - Real World Outcomes. 2020;7(S1):30-35   Crossref logo
Link1 Link2 Link3

Prognostic factors in patients who received end-of-life chemotherapy for advanced cancer
International Journal of Clinical Oncology. 2018;24(4):454-459   Crossref logo
Link1 Link2 Link3

EP08.01-002 Real-World Survival Outcomes of Patients with High PD-L1 Advanced NSCLC Who Received Chemo-Immunotherapy vs Immunotherapy
Journal of Thoracic Oncology. 2022;17(9):S334-S335   Crossref logo
Link1 Link2

PCN524 EUROPEAN REAL-WORLD TREATMENT PATTERNS OF SYSTEMIC THERAPIES FOR SECOND LINE (2L) HEPATOCELLULAR CARCINOMA (HCC) PATIENTS WHO PREVIOUSLY RECEIVED SORAFENIB
Value in Health. 2019;22:S539-S540   Crossref logo
Link1 Link2

TCT-206: Real-World Comparison Of Clinical Outcomes Of Patients Who Received New Generation Platinum Chromium Everolimus-Eluting Stent Versus Cobalt Chromium Everolimus-Eluting Stent
Journal of the American College of Cardiology. 2011;58(20):B55   Crossref logo
Link1 Link2

Outcomes, Safety and Prognostic Factors of Patients Receiving Immune Checkpoint Inhibitors for Urothelial Carcinoma: Analysis of Real World Evidence at Guy’s Hospital
Clinical Oncology. 2020;32(5):e133   Crossref logo
Link1 Link2

Real-World Survival Outcomes and Prognostic Factors Among Patients Receiving First Targeted Therapy for Advanced Renal Cell Carcinoma: A SEER–Medicare Database Analysis
Clinical Genitourinary Cancer. 2017;15(4):e573-e582   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.